Texas A&M Researchers To Further Develop Unique Cancer Drug With $2.3 Million NIH Grant
Preliminary data indicate that the compounds developed in the laboratory of Dr. Stephen Safe both kill tumors and rejuvenate the immune system, which becomes exhausted as it responds to cancer.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed